Clinical Trials In Montreal

Discover hundreds of clinical trials in Montreal.
Search clinical trials in Montreal by condition or phase.

e.g. Respiratory Diseases

Montreal•Healthy volunteers: No

Filter results

Results: 1,133

Norovirus Research for Adults

Recruiting

Phase 3

Sponsor:

Moderna

Location:

Pointe-Claire, Mirabel, Trois-Rivieres, Sherbrookeshow 151 more

Code:

NCT06592794

Conditions

Acute Gastroenteritis

Norovirus Acute Gastroenteritis

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Accepted

Interventions

mRNA-1403

Placebo

A Study Evaluating APG777 in Atopic Dermatitis

Recruiting

PHASE2

Sponsor:

Apogee Therapeutics, Inc.

Location:

Montreal, Quebec, Portsmouth, Peterboroughshow 27 more

Code:

NCT06395948

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

APG777

Placebo

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Montreal, Terrebonne, St Jean sur Richelieu, Trois-Rivieresshow 147 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Recruiting

EARLY_PHASE1

Sponsor:

Canadian Cancer Trials Group

Location:

Montreal, Kingston, Toronto, Vancouver

Code:

NCT04161248

Conditions

Lymphoma, B-Cell

Eligibility Criteria

Sex: All

Age: 16 - 65

Healthy Volunteers: Not accepted

Interventions

Venetoclax

Rituximab Injection

Rituximab SC

Gemcitabine

Dexamethasone

Multimodal Prehabilitation for Lung Cancer Surgery

Recruiting

Sponsor:

Stéphanie Chevalier

Location:

Montreal

Code:

NCT05955248

Conditions

Lung Cancer

Surgery

Eligibility Criteria

Sex: All

Age: 45+

Healthy Volunteers: Not accepted

Interventions

Mixed-nutriend supplement (NUT)

Multimodal Prehabilitation (MM)

Placebo Control (CTRL)

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Montreal, Burlington, Sherbrooke, Lebanonshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Dynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk Factors

Recruiting

Sponsor:

St. Justine's Hospital

Location:

Montreal

Code:

NCT01736748

Conditions

Obese

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Sensor based PA intervention

Traditional PA counseling

Multidisciplinary Approach for High Risk Patients Leading to Early Diagnosis of Canadians in Heart Failure

Recruiting

Sponsor:

Cardiology Research UBC

Location:

Montreal, Sherbrooke, Vancouver

Code:

NCT05859048

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

NT-proBNP

AI echocardiogram

electrocardiogram

Cardiovascular physical examination

Promoting Cognitive Health in Schizophrenia

Recruiting

Sponsor:

Douglas Mental Health University Institute

Location:

Montreal, Ottawa, Kingston, Torontoshow 1 more

Code:

NCT05661448

Conditions

Schizophrenia

Cognition

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cognitive remediation

MetaCognitive Training

Magnetic Gastro-Ileal or Gastro-Jejunal Diversion Study ("MGI/MGJ Study")

Recruiting

Sponsor:

GT Metabolic Solutions, Inc.

Location:

Westmount

Code:

NCT06073457

Conditions

Obesity

Type 2 Diabetes

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

MagGJ System

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

Recruiting

PHASE1

Sponsor:

Genmab

Location:

Montreal, Valhalla, Toronto, Philadelphiashow 6 more

Code:

NCT05206357

Conditions

Non-hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 1 - 25

Healthy Volunteers: Not accepted

Interventions

Epcoritamab